LUMO - Lumos Pharma Inc. (LUMO) CEO Rick Hawkins on Q4 2021 Results - Earnings Call Transcript
Lumos Pharma, Inc. (LUMO) Q4 2021 Earnings Conference Call March 10, 2022, 04:30 PM ET Company Participants Lisa Miller - Senior Director of Investor Relations Rick Hawkins - Chief Executive Officer & Chairman Lori Lawley - Chief Financial Officer & Principal Accounting Officer John McKew - Chief Scientific Officer & President David Karpf - Chief Medical Officer Conference Call Participants Charles Duncan - Cantor Fitzgerald Ed White - H.C. Wainwright Catherine Novack - Jones Research Elemer Piros - ROTH Capital Partners Presentation Operator Good afternoon, and welcome to Lumos Pharma's Fourth Quarter 2021 Results Conference Call. Currently, all participants are in a listen-only mode. Later we will conduct a question and answer session. And instructions will follow at that time. As a reminder, this conference call is being recorded. I will now turn the call over to Lisa Miller, Senior Director of Investor Relations. Ma'am, please go ahead. Lisa Miller
For further details see:
Lumos Pharma, Inc. (LUMO) CEO Rick Hawkins on Q4 2021 Results - Earnings Call Transcript